FR2539993A1 - Balsam which acts on cancerous wounds - Google Patents

Balsam which acts on cancerous wounds Download PDF

Info

Publication number
FR2539993A1
FR2539993A1 FR8301408A FR8301408A FR2539993A1 FR 2539993 A1 FR2539993 A1 FR 2539993A1 FR 8301408 A FR8301408 A FR 8301408A FR 8301408 A FR8301408 A FR 8301408A FR 2539993 A1 FR2539993 A1 FR 2539993A1
Authority
FR
France
Prior art keywords
moucou
acts
balsam
called
wounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR8301408A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DARCHEUX MARIO
Original Assignee
DARCHEUX MARIO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DARCHEUX MARIO filed Critical DARCHEUX MARIO
Priority to FR8301408A priority Critical patent/FR2539993A1/en
Publication of FR2539993A1 publication Critical patent/FR2539993A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

This invention is a balsam which acts on cancerous wounds. It consists of the following components: - arsenic (2 g), - derivative of cassava flour called "couak" (2 g), - hydrogen peroxide (2 g), - medicinal plant called "moucou-moucou" (2 g). It is applied directly to the wound. Effective cure is observed after 2 months.

Description

DESCRIPTION 1) Produit
Cette invention est un baume (pommade) agissant avec une grande efficacité sur les plaies cancéreuses.DESCRIPTION 1) Product
This invention is a balm (ointment) which acts with great effectiveness on cancerous wounds.

2) Origine du produit
Ce produit.est originaire de la Guyane. I1 provient d'un des anciens remèdes de ce département aui servait à l'origine à guérir toute sortes de plaies (tumeurs, brûlures...)
Il y a quelques mois, une jeune personne était atteinte d'un cancer de la peau. Elle revenait d'un centre de cancérologie de 7illejuif. Les professeurs avaient jugé son état désepérd et lui avaient conseillé d'aller vivre ses derniers moments dans son Sle natale. C'est alors qu'il lui a été appliqué ce produit. L'expérience a donné des résultats honorables, mais pour les améliorer encore il était nécéssaire d'ajouter une plante médicinale de Guyane appelée moucou-moucou.Les résultats ont été fulgurants.2) Origin of the product
This product is from Guyana. It comes from one of the ancient remedies of this department which was originally used to heal all kinds of wounds (tumors, burns ...)
A few months ago, a young person had skin cancer. She was coming back from a cancer center in 7illejuif. The teachers had judged his state of despair and advised him to go live his last moments in his native Sle. It was then that this product was applied to him. The experiment gave honorable results, but to further improve it was necessary to add a medicinal plant from Guyana called moucou-moucou. The results were dazzling.

Deux mois plus tard, cette personne était guérie. Actuel- lement, celle-ci est mère de famille et bénéficie d'une santé enviable. Ayant pris connaissance de la nouvelle, un des professeurs de VilleJuiS s'est spécialement déplacé pour constater la guérison.Two months later, this person was healed. Currently, she is a mother and enjoys enviable health. Having heard the news, one of the VilleJuiS professors came specially to see the healing.

3) Composition - arsenic (2 g) - dérivé de la farine de manioc appeié couak (2 g) - eau oxygénée (2 g) - cognac (2 g) - plante mddicinale appelée moucou-moucou (? g)
Ces 5 produits mélangés donnent une matière qui s'apparente è une pommade.3) Composition - arsenic (2 g) - derived from cassava flour called couak (2 g) - hydrogen peroxide (2 g) - cognac (2 g) - medicinal plant called moucou-moucou (? G)
These 5 mixed products give a material similar to an ointment.

4) Anl;cation
L'application de ce produit est très simple. I1 suffit d'étendre généreusement le produit sur la plaie et d'y adjoindre un pansement.4) Anl; cation
The application of this product is very simple. It suffices to generously spread the product over the wound and to add a dressing.

5) Résultats
A partir d'une semaine nous pouvons observer la formation d'un alvéole blanchâtre autour de la plaie. Cet alvéole se fait de plus en plus petite avec le temps et la résorption complète de la tumeur s'effectue au bout de 2 mois. 5) Results
From one week we can observe the formation of a whitish alveolus around the wound. This alveolus becomes smaller and smaller over time and the complete tumor resorption takes place after 2 months.

Claims (1)

REVENDICATION CLAIM Ce produit est un baume anticancéreux caractérisé par les constituants suivants - arsenic (2 g) - dérivé de la farine de manioc appelé couak (2 g) - eau oxygénée (2 g) - cognac (2 g) - plante médicinale appelée moucou-moucou (2 g) This product is an anti-cancer balm characterized by the following constituents - arsenic (2 g) - derived from cassava flour called couak (2 g) - hydrogen peroxide (2 g) - cognac (2 g) - medicinal plant called moucou-moucou (2 g)
FR8301408A 1983-01-28 1983-01-28 Balsam which acts on cancerous wounds Withdrawn FR2539993A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR8301408A FR2539993A1 (en) 1983-01-28 1983-01-28 Balsam which acts on cancerous wounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8301408A FR2539993A1 (en) 1983-01-28 1983-01-28 Balsam which acts on cancerous wounds

Publications (1)

Publication Number Publication Date
FR2539993A1 true FR2539993A1 (en) 1984-08-03

Family

ID=9285414

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8301408A Withdrawn FR2539993A1 (en) 1983-01-28 1983-01-28 Balsam which acts on cancerous wounds

Country Status (1)

Country Link
FR (1) FR2539993A1 (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995022336A1 (en) * 1994-02-18 1995-08-24 Tamara Vasilievna Vorobieva Agent having an immunomodulating effect and reducing disturbed functioning of the tissue cell propagation regulating system
EP0955052A1 (en) * 1998-05-08 1999-11-10 Ill-Ju Bae Arsenic hexaoxide (As4O6) for use in cancer therapy and its pharmaceutical composition
US6723351B2 (en) 1997-11-10 2004-04-20 Memorial Sloan-Kettering Cancer Center Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol
US7138147B2 (en) 1998-04-24 2006-11-21 Daopei Lu Arsenic sulfide compounds and derivatives thereof for the treatment of malignancies
US8394422B2 (en) 2002-04-26 2013-03-12 Centre National De La Recherche Scientifique (Cnrs) Arsenic therapy for autoimmune and/or inflammatory diseases in mice and humans
US8497300B2 (en) 2002-04-26 2013-07-30 Centre National De La Recherche Scientifique (Cnrs) Arsenic therapy for APLS-type autoimmune lymph-oproliferative syndrome in mice and humans

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995022336A1 (en) * 1994-02-18 1995-08-24 Tamara Vasilievna Vorobieva Agent having an immunomodulating effect and reducing disturbed functioning of the tissue cell propagation regulating system
US6884439B2 (en) 1997-11-10 2005-04-26 Memorial Sloan-Kettering Cancer Center Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol
US6723351B2 (en) 1997-11-10 2004-04-20 Memorial Sloan-Kettering Cancer Center Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol
US6855339B2 (en) 1997-11-10 2005-02-15 Memorial Sloan-Kettering Cancer Center Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol
US6861076B2 (en) 1997-11-10 2005-03-01 Memorial Sloan-Kettering Cancer Center Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol
US6982096B2 (en) 1997-11-10 2006-01-03 Memorial Sloan-Kettering Cancer Center Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol
US7879364B2 (en) 1997-11-10 2011-02-01 Memorial Sloan-Kettering Cancer Center Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol
US8273379B2 (en) 1997-11-10 2012-09-25 Memorial Sloan-Kettering Cancer Center Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol
US7138147B2 (en) 1998-04-24 2006-11-21 Daopei Lu Arsenic sulfide compounds and derivatives thereof for the treatment of malignancies
DE19831579A1 (en) * 1998-05-08 1999-11-11 Bae Ill Ju Anticancer drug from arsenic hexoxide
EP0955052A1 (en) * 1998-05-08 1999-11-10 Ill-Ju Bae Arsenic hexaoxide (As4O6) for use in cancer therapy and its pharmaceutical composition
DE19831579B4 (en) * 1998-05-08 2007-03-01 Ill-Ju Bae Anticancer drug from arsenic hexoxide
US8394422B2 (en) 2002-04-26 2013-03-12 Centre National De La Recherche Scientifique (Cnrs) Arsenic therapy for autoimmune and/or inflammatory diseases in mice and humans
US8497300B2 (en) 2002-04-26 2013-07-30 Centre National De La Recherche Scientifique (Cnrs) Arsenic therapy for APLS-type autoimmune lymph-oproliferative syndrome in mice and humans

Similar Documents

Publication Publication Date Title
ATE39323T1 (en) INJECTABLE SOLUTION TO TREAT INFLAMMATION.
US20070098671A1 (en) Composition and method of treatment for irritated skin
CA943453A (en) Evaporative treatment of liquids
ATE56366T1 (en) DRESSING FOR THE TREATMENT OF WOUNDS AND METHOD OF MANUFACTURE.
FR2539993A1 (en) Balsam which acts on cancerous wounds
CA919090A (en) Treatment of blood with oleaginous substance
BR9609033B1 (en) composition and emulsion for the controlled release of a substance.
MX9703354A (en) Acne treating-wound healing compositions containing a pyruvate, an antioxidant and a mixture of fatty acids.
CA948828A (en) Process for the sterilization of medicinal tissue-binding substances
HUP9801898A1 (en) Antipsoriatic nail-lack and process for producing it
CA957942A (en) Flowable pancreatin preparation of low germ content, and a process for its manufacture
FR2460660A1 (en) MAGNETIC THERAPEUTIC ADHESIVE DRESSING
US2267739A (en) Composition of matter for treating skin diseases
ATE50143T1 (en) MEDICATIONS FOR THE TREATMENT OF INVOLUTIVE BRAIN SYNDROMES AND MENTAL DECYCLING.
EP0116362A3 (en) Sterile package for therapeutic composition
FR2614203A1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF SKIN DISEASES AND METHOD FOR THE PREPARATION THEREOF.
SE396071B (en) PROCEDURE FOR THE PREPARATION OF A (C? 716 - C? 7128) -ALKENYL HARBONIC ACID HYDRID-CONDENSATION PRODUCT INCLUDING TREATMENT OF A (C? 716 - C? 7128) -OLEPHINE WITH MALEINIC ACID 1HYTHRAHIANHYTHRAHIANHYRAID 1HYRID
FR2129178A6 (en) Mixer/container - for cosmetic and medical creams and lotions
NL149174B (en) PROCESS FOR THE PREPARATION OF PREPARATIONS EFFECTIVE IN HEART AND CIRCULATION DISEASES, AND FOR THE PREPARATION OF COMPOUNDS, SUITABLE FOR USE IN THAT PROCESS.
CA966777A (en) Delayed action antiseptic composition and the process for its preparation
CA989309A (en) Pharmaceutical composition for the treatment of acne containing fatty acid amides
FR2104911A1 (en) Heterosides from ruscus aculeatus l - useful as antiinflammatories vasconstructors and fibrinolytics
CA1022187A (en) Process for the semihydrogenation of citral to citronellal
RU93011717A (en) MEANS FOR TREATING HYMORITIS
GB1372721A (en) Containers of antiseptics for the treatment of burns and scalds

Legal Events

Date Code Title Description
ST Notification of lapse